Search Result "LY404039"
Molecule of the Month
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1480-1481
Author(s): Evan P. Lebois
Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 94-102
Author(s): Shigeyuki Chaki, Hirohiko Hikichi
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3788-3796
Author(s): Gerard J. Marek
Metabotropic Glutamate Receptors in Central Nervous System Diseases
Journal: Current Drug Targets
Volume: 17 Issue: 5 Year: 2016 Page: 538-616
Author(s):
Progress in the Developement of Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 47-68
Author(s): A. A. Trabanco, J. M. Cid, H. Lavreysen, G. J. Macdonald, G. Tresadern
Conditioned Avoidance Response in the Development of New Antipsychotics
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 358-370
Author(s): M-L. G. Wadenberg
Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 25 Year: 2019 Page: 4885-4913
Author(s): Agnieszka Jankowska,Grzegorz SataÅa,Anna Partyka,Anna WesoÅowska,Andrzej J. Bojarski,Maciej PawÅowski,Grażyna ChÅoÅ-Rzepa
Allosteric Modulators for mGlu Receptors
Journal: Current Neuropharmacology
Volume: 5 Issue: 3 Year: 2007 Page: 187-194
Author(s): F. Gasparini, W. Spooren
Positive Allosteric Modulators for mGluR2 Receptors: A Medicinal Chemistry Perspective
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 15 Year: 2014 Page: 1771-1788
Author(s): Gyorgy Szabo,Gyorgy Miklos Keseru
The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
Journal: Current Neuropharmacology
Volume: 14 Issue: 5 Year: 2016 Page: 514-539
Author(s): Daniel Peterlik,Peter J. Flor,Nicole Uschold-Schmidt